Published in Am J Surg on July 01, 2007
The results of surgery for mediastinal parathyroid tumors: a comparative study of 63 patients. Langenbecks Arch Surg (2010) 0.82
Focused approach to ectopic mediastinal parathyroid surgery assisted by radio-guided navigation. Surg Today (2013) 0.78
Thoracoscopic removal of hypertrophic mediastinal parathyroid glands in recurrent secondary hyperparathyroidism. World J Surg (2015) 0.77
High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines. Cancer Res (2003) 2.49
Effect of the vascular endothelial growth factor receptor-2 antibody DC101 plus gemcitabine on growth, metastasis and angiogenesis of human pancreatic cancer growing orthotopically in nude mice. Int J Cancer (2002) 2.12
Surgeon-performed ultrasound can predict differentiated thyroid cancer in patients with solitary thyroid nodules. Ann Surg Oncol (2009) 2.09
Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate? Surgery (2003) 2.03
Thyroid cancer: is the incidence still increasing? Ann Surg Oncol (2004) 1.82
Thyroidectomy remains an effective treatment option for Graves' disease. Am J Surg (2006) 1.67
Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors. Surgery (2013) 1.62
Quick intraoperative parathyroid hormone assay: surgical adjunct to allow limited parathyroidectomy, improve success rate, and predict outcome. World J Surg (2004) 1.32
Are there gender differences in choosing a surgical career? Surgery (2003) 1.28
Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations. Cancer (2005) 1.26
Blockade of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling for therapy of metastatic human pancreatic cancer. Cancer Res (2002) 1.23
Long-term survival after surgical management of neuroendocrine hepatic metastases. HPB (Oxford) (2010) 1.17
Surgical treatment of non-functioning pancreatic islet cell tumors. J Surg Oncol (2005) 1.16
Fine needle aspiration of the thyroid: correlation with final histopathology in a surgical series of 797 patients. J Am Coll Surg (2011) 1.16
Intraoperative parathyroid hormone levels in thyroid surgery are predictive of postoperative hypoparathyroidism and need for vitamin D supplementation. Am J Surg (2005) 1.16
Heparanase-1 expression is associated with the metastatic potential of breast cancer. Surgery (2002) 1.10
Heparanase-1 gene expression and regulation by high glucose in renal epithelial cells: a potential role in the pathogenesis of proteinuria in diabetic patients. Diabetes (2005) 1.10
Cloning and characterization of the human heparanase-1 (HPR1) gene promoter: role of GA-binding protein and Sp1 in regulating HPR1 basal promoter activity. J Biol Chem (2002) 1.09
Surgical management of primary hyperparathyroidism: state of the art. Surg Clin North Am (2009) 1.06
Incidental papillary carcinoma in patients treated surgically for benign thyroid diseases. Surgery (2009) 1.05
Major histocompatibility complex class I-related chain A/B (MICA/B) expression in tumor tissue and serum of pancreatic cancer: role of uric acid accumulation in gemcitabine-induced MICA/B expression. BMC Cancer (2011) 1.04
Management of biliary and duodenal complications of chronic pancreatitis. World J Surg (2003) 1.03
A CRASH course in procedural skills improves medical students' self-assessment of proficiency, confidence, and anxiety. Am J Surg (2007) 1.03
Progress in the operative management of sporadic primary hyperparathyroidism over 34 years. Ann Surg (2004) 1.00
Medical students' perceptions of resident teaching: have duty hours regulations had an impact? Ann Surg (2005) 0.99
Role of intraoperative parathormone monitoring during parathyroidectomy in patients with discordant localization studies. Surgery (2008) 0.98
Resident education in 2011: three key challenges on the road ahead. Surgery (2011) 0.98
Somatostatin analog treatment of a cervical thoracic duct fistula. Head Neck (2002) 0.98
Elevated serum heparanase-1 levels in patients with pancreatic carcinoma are associated with poor survival. Cancer (2006) 0.97
Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis. Clin Cancer Res (2003) 0.96
Surgeon-performed ultrasound: a single institution experience in parathyroid localization. Surgery (2009) 0.95
Human heparanase-1 gene expression in pancreatic adenocarcinoma. J Gastrointest Surg (2002) 0.95
Central pancreatectomy for the resection of benign or low malignant potential neoplasms. World J Surg (2003) 0.94
Outcome of laparoscopic adrenalectomy for pheochromocytomas vs aldosteronomas. Arch Surg (2004) 0.94
Operative failure in the era of focused parathyroidectomy: a contemporary series of 845 patients. Arch Surg (2010) 0.93
Parathyroidectomy outcomes according to operative approach. Am J Surg (2007) 0.93
Developments in the use of ultrasound for thyroid cancer. Curr Opin Oncol (2010) 0.93
Intraoperative PTH monitoring in parathyroid hyperplasia requires stricter criteria for success. Surgery (2004) 0.92
Sporadic primary hyperparathyroidism in young individuals: different disease and treatment? J Surg Res (2008) 0.91
Benefits of surgeon-performed ultrasound for primary hyperparathyroidism. Langenbecks Arch Surg (2009) 0.91
Adrenocorticotropic hormone-secreting pancreatic islet cell carcinoma. J Am Coll Surg (2004) 0.91
Activation of the Sonic Hedgehog pathway in thyroid neoplasms and its potential role in tumor cell proliferation. Endocr Relat Cancer (2012) 0.90
Long-term results of parathyroidectomy for hypercalcemic crisis. Arch Surg (2006) 0.89
Primary hyperaldosteronism in the era of laparoscopic adrenalectomy. Am Surg (2002) 0.89
An algorithm to maximize use of minimally invasive parathyroidectomy. Arch Surg (2004) 0.89
Consequences of targeted parathyroidectomy guided by localization studies without intraoperative parathyroid hormone monitoring. J Am Coll Surg (2006) 0.89
Complete androgen insensitivity syndrome: the role of the endocrine surgeon. Am Surg (2005) 0.89
In vivo and in vitro degradation of heparan sulfate (HS) proteoglycans by HPR1 in pancreatic adenocarcinomas. Loss of cell surface HS suppresses fibroblast growth factor 2-mediated cell signaling and proliferation. J Biol Chem (2006) 0.89
Toxic nodular goiter and cancer: a compelling case for thyroidectomy. Ann Surg Oncol (2012) 0.88
The sonic hedgehog signaling pathway maintains the cancer stem cell self-renewal of anaplastic thyroid cancer by inducing snail expression. J Clin Endocrinol Metab (2014) 0.88
Is potassium iodide solution necessary before total thyroidectomy for Graves disease? Ann Surg Oncol (2013) 0.88
Greater local recurrence occurs with "berry picking" than neck dissection in thyroid cancer. Am Surg (2003) 0.87
Ductal carcinoma in situ of the breast and heparanase-1 expression: a molecular explanation for more aggressive subtypes. J Am Coll Surg (2005) 0.86
Predictors of hemodynamic instability during surgery for pheochromocytoma. Ann Surg Oncol (2014) 0.86
Estradiol induces heparanase-1 expression and heparan sulphate proteoglycan degradation in human endometrium. Hum Reprod (2007) 0.86
Use of ultrasound in the management of thyroid cancer. Oncologist (2010) 0.86
Impact of surgical mentorship on retroperitoneoscopic adrenalectomy with comparison to transperitoneal laparoscopic adrenalectomy. Am Surg (2013) 0.85
Surgical management of well-differentiated thyroid cancer locally invasive to the respiratory tract. J Am Coll Surg (2005) 0.84
Intraoperative total serum calcium levels, unlike intraoperative intact PTH levels, do not correlate with cure of hyperparathyroidism. J Surg Res (2003) 0.84
Clinicopathological significance of major histocompatibility complex class I-related chain a and B expression in thyroid cancer. J Clin Endocrinol Metab (2006) 0.84
Pheochromocytoma presenting with multiple organ failure. Am Surg (2008) 0.84
A prospective evaluation of the effect of sample collection site on intraoperative parathormone monitoring during parathyroidectomy. Surgery (2008) 0.83
Metastatic choriocarcinoma to the pancreas. Am Surg (2005) 0.83
Are patients of low socioeconomic status receiving suboptimal management for pancreatic adenocarcinoma? Cancer (2010) 0.83
Short-term outcomes of parathyroidectomy in patients with or without 25-hydroxy vitamin D insufficiency. J Surg Res (2007) 0.82
Induction of heparanase-1 expression by mutant B-Raf kinase: role of GA binding protein in heparanase-1 promoter activation. Neoplasia (2010) 0.82
Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism. Surgery (2007) 0.82
CA 19-9 nonproduction is associated with poor survival after resection of pancreatic adenocarcinoma. Am J Clin Oncol (2014) 0.81
Recurrent disease after limited parathyroidectomy for sporadic primary hyperparathyroidism. J Am Coll Surg (2004) 0.81
Outcomes of pheochromocytoma management in the laparoscopic era. Ann Surg Oncol (2007) 0.81
Trends in thyroid surgery in Illinois. Surgery (2013) 0.80
Vascular complications associated with pancreaticoduodenectomy adversely affect clinical outcome. Surgery (2002) 0.80
Same-day ultrasound guidance in reoperations for locally recurrent papillary thyroid cancer. Surgery (2007) 0.80
Expense of robotic thyroidectomy: a cost analysis at a single institution. Arch Surg (2012) 0.80
Defining quality for distal pancreatectomy: does the laparoscopic approach protect patients from poor quality outcomes? J Gastrointest Surg (2012) 0.80
Thyroidectomy as primary treatment optimizes body mass index in patients with hyperthyroidism. Ann Surg Oncol (2014) 0.80
Comparison of tumor markers for predicting outcomes after resection of nonfunctioning pancreatic neuroendocrine tumors. Surgery (2014) 0.79
Does histopathology predict parathyroid hypersecretion and influence correctly the extent of parathyroidectomy in patients with sporadic primary hyperparathyroidism? Surgery (2007) 0.79
Low frequency of BRAF mutations in adult patients with papillary thyroid cancers following childhood radiation exposure. Thyroid (2006) 0.79
Do intraoperative total serum and ionized calcium levels, like intraoperative intact PTH levels, correlate with cure of hyperparathyroidism? World J Surg (2005) 0.78
Using a modification of the Clavien-Dindo system accounting for readmissions and multiple interventions: defining quality for pancreaticoduodenectomy. J Surg Oncol (2014) 0.78
Neurofibromatosis-associated pheochromocytoma. J Am Coll Surg (2005) 0.78
Variations in clinicopathologic characteristics of thyroid cancer among racial ethnic groups: analysis of a large public city hospital and the SEER database. Am J Surg (2013) 0.78
Lithium use and primary hyperparathyroidism. Endocr Pract (2011) 0.77
Expression of the sonic hedgehog pathway molecules in synchronous follicular adenoma and papillary carcinoma of the thyroid gland in predicting malignancy. Surgery (2010) 0.77
Expression of Receptors for Pituitary-Type Growth Hormone-Releasing Hormone (pGHRH-R) in Human Papillary Thyroid Cancer Cells: Effects of GHRH Antagonists on Matrix Metalloproteinase-2. Horm Cancer (2015) 0.77
Long-term outcome of patients with intraoperative parathyroid level remaining above the normal range during parathyroidectomy. Surgery (2008) 0.77
The pathological features of surgically managed adrenal cysts: a 15-year retrospective review. Am Surg (2013) 0.76
Does homocysteine contribute to bone disease in hyperparathyroidism? Am J Surg (2008) 0.76
TIMING OF RADIOACTIVE IODINE THERAPY DOES NOT IMPACT OVERALL SURVIVAL IN HIGH-RISK PAPILLARY THYROID CARCINOMA. Endocr Pract (2016) 0.76
Major depression due to primary hyperparathyroidism: a frequent and correctable disorder. Am Surg (2004) 0.76
Primary hyperparathyroidism in the underinsured: a study of 493 patients. Surgery (2011) 0.76